Estrogen receptor α mediated induction of the transforming growth factor α gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells

This publication has 46 references indexed in Scilit:

• Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
  JNCI Journal of the National Cancer Institute, 1998
• Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists
  Molecular Pharmacology, 1998
• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Molecular basis of agonism and antagonism in the oestrogen receptor
  Nature, 1997
• Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue
  Cancer Letters, 1995
• Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor
  Endocrinology, 1995
• Blockade of the Epidermal Growth Factor Receptor Inhibits Transforming Growth Factor α-Induced but Not Estrogen-Induced Growth of Hormone-Dependent Human Breast Cancer
  Molecular Endocrinology, 1988
• Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional Significance
  Molecular Endocrinology, 1988
• Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
  Nature, 1986